Zimmer Biomet Holdings (XSWX:ZBH) 3-Year Book Growth Rate : 1.10% (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Zimmer Biomet Holdings 3-Year Book Growth Rate?

Zimmer Biomet Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was CHF52.50.

During the past 12 months, Zimmer Biomet Holdings's average Book Value per Share Growth Rate was 5.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 1.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was 1.10% per year. During the past 10 years, the average Book Value per Share Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Zimmer Biomet Holdings was 240.70% per year. The lowest was -1.50% per year. And the median was 8.00% per year.

Competitive Comparison of Zimmer Biomet Holdings's 3-Year Book Growth Rate

For the Medical Devices subindustry, Zimmer Biomet Holdings's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zimmer Biomet Holdings's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's 3-Year Book Growth Rate falls into.

Zimmer Biomet Holdings 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Zimmer Biomet Holdings (XSWX:ZBH) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Zimmer Biomet Holdings 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Zimmer Biomet Holdings (XSWX:ZBH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (XSWX:ZBH) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

ZBH:USA ZIM:Germany ZBH:Austria

Address

345 East Main Street, Warsaw, IN, USA, 46580

Website

https://www.zimmerbiomet.com

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.